Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human GLUT1 Antibodies:
anti-Mouse (Murine) GLUT1 Antibodies:
anti-Rat (Rattus) GLUT1 Antibodies:
Go to our pre-filtered search.
Human Polyclonal GLUT1 Primary Antibody for ELISA, ICC - ABIN152817
Minamishima, Moslehi, Bardeesy, Cullen, Bronson, Kaelin: Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure. in Blood 2008
Show all 18 Pubmed References
Human Polyclonal GLUT1 Primary Antibody for ChIP, FACS - ABIN258123
Hergovich, Lisztwan, Thoma, Wirbelauer, Barry, Krek: Priming-dependent phosphorylation and regulation of the tumor suppressor pVHL by glycogen synthase kinase 3. in Molecular and cellular biology 2006
Show all 14 Pubmed References
Human Monoclonal GLUT1 Primary Antibody for CyTOF, FACS - ABIN4899145
Jain, Manuel, Khan, Ahuja, Quann, Wigdahl: DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells. in Journal of virology 2009
Show all 9 Pubmed References
Human Polyclonal GLUT1 Primary Antibody for IHC (p), WB - ABIN4886725
Xu, Bao, Zhou, Fan: Effect on the expression of MMP-2, MT-MMP in laryngeal carcinoma Hep-2 cell line by antisense glucose transporter-1. in Archives of medical research 2012
Show all 6 Pubmed References
Human Monoclonal GLUT1 Primary Antibody for FACS - ABIN4895661
Patsoukis, Bardhan, Chatterjee, Sari, Liu, Bell, Karoly, Freeman, Petkova, Seth, Li, Boussiotis: PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. in Nature communications 2015
Show all 5 Pubmed References
Human Monoclonal GLUT1 Primary Antibody for FACS - ABIN4895663
Prost, Relouzat, Spentchian, Ouzegdouh, Saliba, Massonnet, Beressi, Verhoeyen, Raggueneau, Maneglier, Castaigne, Chomienne, Chrétien, Rousselot, Leboulch: Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists. in Nature 2015
Show all 3 Pubmed References
Human Polyclonal GLUT1 Primary Antibody for FACS, ICC - ABIN5076961
Rodríguez-Espinosa, Rojas-Espinosa, Moreno-Altamirano, López-Villegas, Sánchez-García: Metabolic requirements for neutrophil extracellular traps formation. in Immunology 2015
Show all 2 Pubmed References
Human Monoclonal GLUT1 Primary Antibody for FACS - ABIN4895662
Feldhoff, Rueda, Moreno-Fernandez, Sauer, Jackson, Chougnet, Rupp: IL-1β induced HIF-1α inhibits the differentiation of human FOXP3+T cells. in Scientific reports 2017
Human Monoclonal GLUT1 Primary Antibody for FACS - ABIN4895659
Palmer, Ostrowski, Gouillou, Tsai, Yu, Zhou, Henstridge, Maisa, Hearps, Lewin, Landay, Jaworowski, McCune, Crowe: Increased glucose metabolic activity is associated with CD4+ T-cell activation and depletion during chronic HIV infection. in AIDS 2014
Human Polyclonal GLUT1 Primary Antibody for IHC, ELISA - ABIN1582249
Wang, Li, Gao, Lu, Zhang, Ma, Ye, Zhang: Cardiotrophin-1 (CTF1) ameliorates glucose-uptake defects and improves memory and learning deficits in a transgenic mouse model of Alzheimer's disease. in Pharmacology, biochemistry, and behavior 2013
In preeclampsia, placental GLUT1 expression and function are down-regulated at the apical plasma membrane of the syncytiotrophoblast.
High glut1 expression is associated with Pancreatic Cancer.
Study confirms the high expression of Glut-1 not only in endometrioid carcinomas but also in other carcinomas of endometrium including clear cell and serous types. Glut-1 expression can be used as a surrogate marker in differential diagnosis between hyperplasia with and without atypia.
This systematic review and meta-analysis indicated that the GLUT1 may serve as an ideal prognostic biomarker in various cancers.
This study did not detect any pathogenic mutations in SLC2A1 in the patient with focal epilepsy.
Taken together, our study provides a new perspective of miR (show MLXIP Antibodies)-148b in gastric cancer (GC) development through inhibiting glycolysis in GC cells , directly targeting glucose transporter SLC2A1.
Data suggest that plasma glycation with erythrocyte membrane modification is associated with oxidative stress, GLUT1 expression, and erythrocyte fragility in patients with type 2 diabetes; such glycation may further contribute to progression of diabetic vascular complications.
Antibody therapy targeted at AFP-producing tumor cells showed an inhibitory effect on the PI3K/AKT pathway via the liberation, restoration and functional stabilization of PTEN. PTEN simultaneously induced both P53 activation and intracellular translocation of GLUT1, since these are closely associated with PTEN.
FOXM1 (show FOXM1 Antibodies) bound directly to the GLUT1 and HK2 (show HK2 Antibodies) promoter regions and regulated the promoter activities and the expression of the genes at the transcriptional level. This reveals a novel mechanism by which glucose metabolism is regulated by FOXM1 (show FOXM1 Antibodies).
Whereas, Glut1-mediated glucose uptake also requires mTORC2 (show CRTC2 Antibodies) phosphorylation of the hydrophobic domain, demonstrating both phosphorylation-dependent and independent roles of the hydrophobic domain in regulating glucose uptake.
Immunoreactivity of vGluT1 in continuous theta-burst stimulation (iTBS; cTBS (show CTBS Antibodies)) repeated session (RS) decreased, while GLT-1 (show SLC1A2 Antibodies) increased in cTBS (show CTBS Antibodies) SS and cTBS (show CTBS Antibodies) RS, compared to control
Expression of GLUT1 is stimulated by hyperglycemia and low oxygen supply, and this overexpression was associated with increased activity of GLUT1 in the cell membrane that contributes to the impairment of the RPE (show RPE Antibodies) secretory function of PEDF (show SERPINF1 Antibodies).
GLUT1 may play an important role in Prostate Cancer progression via mediating glycolysis and proliferation. There is potential crosstalk between GLUT1-mediated glycolysis and androgen sensitivity in Prostate Cancer.
ARAP2 (show ARAP2 Antibodies) knockdown did not affect fatty acid uptake but reduced basal glucose uptake, total levels of the glucose transporter GLUT1, and GLUT1 levels in the plasma membrane and the lipid micro-domain fraction.
TBC1D5 (show TBC1D5 Antibodies) shuttling to autophagosomes during metabolic stress facilitates retromer-dependent GLUT1 trafficking.
inhibition of GLUT1 activity and/or expression is shown to impair TGF-beta (show TGFB1 Antibodies)-driven fibrogenic processes, including cell proliferation and production of profibrotic mediators
B cell leukemia-induced inhibition of T cell Akt (show AKT1 Antibodies)/mTORC1 signaling and glucose metabolism drives T cell dysfunction; metabolic defects included reduced Akt (show AKT1 Antibodies)/mammalian target of rapamycin (show FRAP1 Antibodies) complex 1 (mTORC1) signaling, decreased expression of the glucose transporter Glut1 and hexokinase 2 (show HK2 Antibodies), and reduced glucose uptake
This study demonstrates a strict requirement for GLUT1 in the early stages of mammary tumorigenesis in vitro and in vivo.
GLUT1-dependent glycolysis regulates fibrogenesis in aged lung.
Data (including data from studies using transgenic mice) suggest that Glut1 (glucose transporter type 1) is a critical downstream target of Hif1a (hypoxia-inducible factor 1 (show HIF1A Antibodies), alpha subunit (show POLG Antibodies)) mediating hyperglycemia-induced extracellular matrix accumulation in kidney via regulation of Nox4 (show NOX4 Antibodies) (NADPH oxidase (show NOX1 Antibodies) type 4) expression in nephropathy due to diabetes type 1.
pGlcT, together with MEX1, contributes significantly to the export of starch degradation products from chloroplasts in A. thaliana leaves and and that this starch-mediated pathway for photoassimilate export via pGlcT and MEX1 is essential for the growth and development of A. thaliana. [pGlcT]
Low GLUT1 and GLUT3 (show SLC2A3 Antibodies) expression in nonclassical monocytes was unaltered during differentiation into macrophages. GLUT4 (show SLC2A4 Antibodies) mRNA was only detectable in unstimulated macrophages. Neither monocytes nor macrophages were insulin (show INS Antibodies) responsive.
the different conformations of the GLUT-1 transporter in luminal (blood facing) and abluminal (brain facing) membranes of bovine cerebral endothelial cells arise from differential phosphorylation of GLUT-1
Significant increases in GLUT1 gene expression were observed during early lactation.
Hyperthermia-induced Hsp90 (show HSP90 Antibodies).eNOS (show NOS3 Antibodies) preserves mitochondrial respiration in hyperglycemic endothelial cells by down-regulating Glut-1 and up-regulating G6PD (show G6PD Antibodies) activity.
distinct domains of the glucose transporter GLUT1 mediate HTLV envelope binding and virus entry
Expression of GLUT1 was evaluated in LLC-PK1 cells grown on porous membranes for the development of an artificial kidney.
results suggest that glucose is transported to the axonal cleft intracytoplasmically and delivered to the cleft by GLUT1 transporters
This gene encodes a major glucose transporter in the mammalian blood-brain barrier. The encoded protein is found primarily in the cell membrane and on the cell surface, where it can also function as a receptor for human T-cell leukemia virus (HTLV) I and II. Mutations in this gene have been found in a family with paroxysmal exertion-induced dyskinesia.
, glucose transporter type 1, erythrocyte/brain
, hepG2 glucose transporter
, human T-cell leukemia virus (I and II) receptor
, solute carrier family 2, facilitated glucose transporter member 1
, solute carrier family 2, member 1
, Solute carrier family 2 a 1 (facilitated glucose transporter) brain
, Solute carrier family 2, facilitated glucose transporter member 1
, solute carrier family 2 (facilitated glucose transporter), member 1
, solute carrier family 2 member 1
, glucose transporter protein
, glucose transporter type 1
, solute carrier family 2 (facilitated glucose transporter), member 1 L homeolog
, glucose transport protein